| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.91B | 46.22B | 34.98B | 25.84B | 21.67B | 21.15B |
| Gross Profit | 33.26B | 44.55B | 31.42B | 22.88B | 19.01B | 18.60B |
| EBITDA | 35.92B | 37.82B | 33.54B | 25.36B | 19.33B | 19.18B |
| Net Income | 26.04B | 28.58B | 24.60B | 19.43B | 14.23B | 13.93B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 99.91B | 87.51B | 75.54B | 65.36B | 58.80B |
| Cash, Cash Equivalents and Short-Term Investments | 79.33B | 547.40M | 418.00M | 400.20M | 70.30M | 13.47B |
| Total Debt | 0.00 | 0.00 | 1.44B | 1.25B | 1.30B | 1.10B |
| Total Liabilities | -81.30B | 7.63B | 6.21B | 4.79B | 4.28B | 3.50B |
| Stockholders Equity | 81.30B | 92.29B | 81.30B | 70.75B | 61.08B | 55.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 25.48B | 20.30B | 15.96B | 11.35B | 12.44B |
| Operating Cash Flow | 0.00 | 25.70B | 20.75B | 16.15B | 11.49B | 12.54B |
| Investing Cash Flow | 0.00 | -6.86B | -5.98B | -5.42B | -2.17B | -5.08B |
| Financing Cash Flow | 0.00 | -18.86B | -14.75B | -10.66B | -9.30B | -7.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ₹1.17T | 33.19 | ― | 0.83% | 13.84% | 15.97% | |
81 Outperform | ₹308.40B | 26.02 | ― | 3.09% | 3.71% | 4.64% | |
77 Outperform | ₹625.00B | 34.69 | ― | 2.14% | 13.07% | 7.83% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ₹118.82B | 29.75 | ― | 2.30% | -7.81% | -45.00% | |
60 Neutral | ₹422.12B | 33.34 | ― | 1.02% | 21.60% | 11.09% |